首页> 外文期刊>Journal of Solid Tumors >Role of thyroid scintigraphy vs. fine needle aspiration cytology in the clinical evaluation of solitary thyroid nodule a clinicoradiopathologic study
【24h】

Role of thyroid scintigraphy vs. fine needle aspiration cytology in the clinical evaluation of solitary thyroid nodule a clinicoradiopathologic study

机译:甲状腺闪烁显像与细针穿刺细胞学检查在孤立性甲状腺结节临床评估中的作用临床放射病理学研究

获取原文
       

摘要

To asses the value of qualitative and quantitative analysis of the radioisotopes 99mTc tetrofosmin (Myoview) and 99mTc (V) DMSA in the evaluation of malignant solitary thyroid cold nodule pre-operatively and to verify their exact value in diagnosis of differentiated thyroid carcinoma. In general there is a 5%-10% chance of malignancy in all thyroid nodules for the total population with higher incidence in single cold nodule than in multinodular goiter. The main role of 99mTc (V) DMSA as a tumor imaging agent is in the diagnosis and follow-up of patients with medullary cancer thyroid. This work included 103 patients, 88 females and 15 males with a mean age of (37.86±13.59 years). All studied were subjected to history taking, proper clinical examination, thyroid function test profile, thyroid radioisotope imaging (99mTc pertechnetate, 99mTc tetrofosmin and 99mTc (V) DMSA thyroid scans) and cytologic assessment of thyroid nodule proved to be cold on conventional thyroid scan. The current study combined both 99mTc tetrofosmin and 99mTc (V) DMSA to evaluate thyroid cold nodules and to verify possibility to differentiate between benign and malignant lesions preoperatively and as confirmed on cytology of lesions obtained by fine needle aspiration cytology (FNAC) modality. Our results showed that 99mTc pertechnetate scan alone is not a reliable diagnostic tool to differentiate between benign and malignant thyroid nodules and that high early myoview uptake in the cold nodule is not specific for malignancy, it is also concluded that both 99mTc tetrofosmin and 99mTc (V) DMSA thyroid scans are valuable diagnostic tools when combined together.
机译:为了评估放射性同位素99mTc trotrofosmin(Myoview)和99mTc(V)DMSA的定性和定量分析在术前评估恶性孤立性甲状腺冷结节中的价值,并验证其在诊断分化型甲状腺癌中的准确价值。总的来说,所有人群甲状腺结节的恶性几率均在5 %-10 %之间,其中单个冷结节的发病率高于多结节性甲状腺肿。 99mTc(V)DMSA作为肿瘤显像剂的主要作用是在甲状腺髓样癌患者的诊断和随访中。这项工作包括103例患者,其中88例女性和15例男性,平均年龄为(37.86±13.59岁)。所有研究对象均接受了历史记录,适当的临床检查,甲状腺功能检查概况,甲状腺放射性同位素显像(99mTc高tech酸盐,99mTc trotrofosmin和99mTc(V)DMSA甲状腺扫描),并在常规甲状腺扫描中对甲状腺结节进行了细胞学评估。当前的研究结合了99mTc trotrofosmin和99mTc(V)DMSA来评估甲状腺冷结节,并验证术前区分良性和恶性病变的可能性,并通过细针穿刺细胞学(FNAC)方式获得的病变细胞学得到证实。我们的研究结果表明,单独进行99mTc高net酸盐扫描不是区分良性和恶性甲状腺结节的可靠诊断工具,并且在寒冷结节中早期的高眼肌摄取量不是恶性肿瘤的特异性,还得出结论,99mTc trotrofosmin和99mTc(V )DMSA甲状腺扫描结合在一起时是有价值的诊断工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号